summary
Introduced
03/09/2020
03/09/2020
In Committee
03/09/2020
03/09/2020
Crossed Over
Passed
Dead
12/31/2020
12/31/2020
Introduced Session
191st General Court
Bill Summary
Relative to opioid drug manufacturer assessments
AI Summary
This bill establishes an assessment on opioid drug manufacturers in Massachusetts based on their annual distribution and dispensing of opioid drugs in the state. The assessment funds will be deposited into the Opioid Treatment and Addiction Prevention Fund, which will be used to provide prevention, treatment, and recovery services, as well as research to reduce barriers to effective pain management alternatives to opioid drugs. The bill requires the Department of Public Health to promulgate regulations to implement the assessment within 180 days of the effective date, and Section 1 of the bill will take effect on June 30, 2020.
Committee Categories
Health and Social Services
Sponsors (22)
Michael Brady (D),
Gerry Cassidy (D),
Claire Cronin (D),
Josh Cutler (D),
Shawn Dooley (R),
Carolyn Dykema (D),
Lori Ehrlich (D),
Tricia Farley-Bouvier (D),
Carole Fiola (D),
Bill Galvin (D),
Randy Hunt (R),
Louis Kafka (D),
Hannah Kane (R),
Rady Mom (D),
Brian Murray (D),
Jim O'Day (D),
Sarah Peake (D),
Smitty Pignatelli (D),
Dave Rogers (D),
Jeff Roy (D),
Aaron Vega (D),
Bud Williams (D),
Other Sponsors (1)
Joint Committee on Mental Health, Substance Use and Recovery (J)
Last Action
Reporting date extended to Thursday December 31, 2020, pending concurrence (on 06/22/2020)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://malegislature.gov/Bills/191/H4532 |
| Bill | https://malegislature.gov/Bills/191/H4532.pdf |
Loading...